These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3734187)

  • 1. Vascular amyloid in a patient with multiple myeloma.
    Henry RB; Fisher GB; Cooper PH
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 2):379-82. PubMed ID: 3734187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blue man: a novel cutaneous manifestation of systemic amyloidosis.
    Campbell M; Rosenthal A; Kundranda M; Pickert A; Dicaudo D; Dogan A; Mikhael J
    Amyloid; 2011 Sep; 18(3):156-9. PubMed ID: 21506660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual bleeding manifestations of amyloidosis in patients with multiple myeloma.
    Rapoport M; Yona R; Kaufman S; Segal M; Kornberg A
    Clin Lab Haematol; 1994 Dec; 16(4):349-53. PubMed ID: 7736713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloid.
    Smith RR; Hutchins GM; Moore GW; Humphrey RL
    Am J Med; 1979 Jan; 66(1):96-104. PubMed ID: 420256
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intermittent claudication disclosing amyloidosis in a chronically hemodialysed patient with light-chain myeloma].
    Prinseau J; Bleibel JM; Hauw JJ; Goupil A; Poisson M; Baglin A; Fritel D
    Ann Med Interne (Paris); 1983; 134(4):323-6. PubMed ID: 6614711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial amino acid sequence of an amyloid fibril protein from unusual cutaneous cystic lesions in myeloma-associated amyloidosis.
    Akiyama T; Seishima M; Nojiri M; Satoh M; Ichiki Y; Kitajima Y
    Eur J Dermatol; 1999 Dec; 9(8):624-8. PubMed ID: 10586130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cutaneous amyloidoses. II. Systemic forms.
    Brownstein MH; Helwig EB
    Arch Dermatol; 1970 Jul; 102(1):20-8. PubMed ID: 5497171
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary arterial hypertension due to pulmonary vascular amyloid deposition in a patient with multiple myeloma.
    Hashimoto H; Kurata A; Mizuno H; Nashiro T; Hangaishi A; Kuroda M; Usuki K; Horiuchi H
    Int J Clin Exp Pathol; 2015; 8(11):15391-5. PubMed ID: 26823900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition of amyloid in the gastrointestinal tract.
    Gilat T; Revach M; Sohar E
    Gut; 1969 Feb; 10(2):98-104. PubMed ID: 5766053
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete ophthalmoplegia secondary to amyloidosis associated with multiple myeloma.
    Raflo GT; Farrell TA; Sioussat RS
    Am J Ophthalmol; 1981 Aug; 92(2):221-4. PubMed ID: 7270637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive haemorrhagic-bullous skin manifestation of systemic AA-amyloidosis associated with IgGlambda-myeloma.
    Grundmann JU; Bonnekoh B; Gollnick H
    Eur J Dermatol; 2000 Mar; 10(2):139-42. PubMed ID: 10694315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elastolytic cutaneous lesions in myeloma-associated amyloidosis.
    Yoneda K; Kanoh T; Nomura S; Ozaki M; Imamura S
    Arch Dermatol; 1990 May; 126(5):657-60. PubMed ID: 2334187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amyloidosis in plasmacytic myeloma with dominant manifestations of joint involvement].
    Janousek J; Alusík S; Pelísková Z; Trnavský K
    Cas Lek Cesk; 1989 May; 128(19):599-601. PubMed ID: 2743385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid in localized cutaneous amyloidosis: immunofluorescence studies with anti-keratin antiserum especially concerning the difference between systemic and localized cutaneous amyloidosis.
    Masu S; Hosokawa M; Seiji M
    Acta Derm Venereol; 1981; 61(5):381-4. PubMed ID: 6172924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusively vascular systemic amyloidosis with visceral ischemia.
    Jennette JC; Sheps DS; McNeill DD
    Arch Pathol Lab Med; 1982 Jul; 106(7):323-7. PubMed ID: 6896444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding tendency caused by the deposit of amyloid substance in the perivascular region.
    Hoshino Y; Hatake K; Muroi K; Tsunoda S; Suzuki T; Miwa A; Sakamoto S; Miura Y
    Intern Med; 1993 Nov; 32(11):879-81. PubMed ID: 8012092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic amyloidosis. A report of 19 cases.
    Wong CK; Wang WJ
    Dermatology; 1994; 189(1):47-51. PubMed ID: 8003785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid myopathy presenting with distal atrophic weakness.
    Smestad C; Monstad P; Lindboe CF; Mygland A
    Muscle Nerve; 2004 Apr; 29(4):605-9. PubMed ID: 15052628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary systemic amyloidosis associated with multiple myeloma: a case report and review of the literature.
    Mason AR; Rackoff EM; Pollack RB
    Cutis; 2007 Sep; 80(3):193-200. PubMed ID: 17956007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autopsy case of amyloidosis with marked cardiac and pulmonary lesions associated with myeloma, initially presenting with muscle weakness].
    Kiryu T; Kobayashi H; Kawaguchi S; Kanou S; Uwabe Y; Nagata N; Kawai T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Jan; 32(1):106-10. PubMed ID: 8114366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.